Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
coronary artery disease
MedTech
Bos Sci nets first US approval for drug-coated coronary balloon
Boston Scientific has received FDA approval for its Agent drug-coated balloon nearly a decade after it made its European debut.
Conor Hale
Mar 1, 2024 1:49pm
Imbria hits goal in angina trial days after heart failure win
Nov 13, 2023 6:10am
Bos Sci's drug-coated coronary balloon outperforms angioplasty
Oct 26, 2023 11:35am
Money continues to flow for HeartFlow with $215M VC raise
Apr 6, 2023 10:05am
Abbott to acquire Cardiovascular Systems for $890M
Feb 9, 2023 10:45am
Medtronic stents net FDA OK to treat coronary artery junctions
Sep 21, 2022 11:38am